Literature DB >> 18761260

Continuing improvement of cardiac sympathetic activity on I-123 MIBG scintigraphy in a patient with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.

Satoshi Okayama1, Shiro Uemura, Manabu Horii, Hiroyuki Kawata, Yoshihiko Saito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18761260     DOI： 10.1016/j.nuclcard.2008.06.015

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  12 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy.

Authors:  Shinro Matsuo; Yasuyuki Nakamura; Takayoshi Tsutamoto; Masahiko Kinoshita
Journal:  J Nucl Cardiol       Date:  2002 Jul-Aug       Impact factor: 5.952

3.  Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy.

Authors:  K Nakajima; H Bunko; J Taki; M Shimizu; A Muramori; K Hisada
Journal:  Am Heart J       Date:  1990-06       Impact factor: 4.749

4.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

Authors:  U Sigwart
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

Review 5.  Hypertrophic cardiomyopathy.

Authors:  Perry Elliott; William J McKenna
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

6.  Cardiac sympathetic nerve activity can detect congestive heart failure sensitively in patients with hypertrophic cardiomyopathy.

Authors:  Go Hiasa; Mareomi Hamada; Hideyuki Saeki; Akiyoshi Ogimoto; Tomoaki Ohtsuka; Yuji Hara; Yuji Shigematsu
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

7.  Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.

Authors:  Hidenobu Terai; Masami Shimizu; Hidekazu Ino; Masato Yamaguchi; Katsuharu Uchiyama; Kotaro Oe; Kenichi Nakajima; Junichi Taki; Masaya Kawano; Hiroshi Mabuchi
Journal:  J Nucl Med       Date:  2003-10       Impact factor: 10.057

8.  Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias.

Authors:  Hidenobu Terai; Masami Shimizu; Hidekazu Ino; Masato Yamaguchi; Kenshi Hayashi; Kenji Sakata; Masaru Kiyama; Tatsumi Hayashi; Masaru Inoue; Junichi Taki; Hiroshi Mabuchi
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

9.  The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.

Authors:  Camillo Autore; Paola Bernabò; Caterina Stella Barillà; Paolo Bruzzi; Paolo Spirito
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

Review 10.  The management of hypertrophic cardiomyopathy.

Authors:  P Spirito; C E Seidman; W J McKenna; B J Maron
Journal:  N Engl J Med       Date:  1997-03-13       Impact factor: 91.245
View more
  1 in total

Review 1.  Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy.

Authors:  Derk O Verschure; Berthe L F van Eck-Smit; G Aernout Somsen; Hein J Verberne
Journal:  Clin Transl Imaging       Date:  2015-08-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.